Roland Andersson Selected Research

Mucin-4

5/2017	Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine.
10/2014	Apicidin sensitizes pancreatic cancer cells to gemcitabine by epigenetically regulating MUC4 expression.
8/2014	Analysis of MUC4 expression in human pancreatic cancer xenografts in immunodeficient mice.
10/2013	Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland Andersson Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 08/2002
48	Pancreatic Neoplasms (Pancreatic Cancer) 04/2021 - 01/2009
26	Pancreatitis 04/2022 - 10/2002
15	Adenocarcinoma 10/2019 - 06/2007
12	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2010
7	Pain (Aches) 10/2013 - 04/2002
5	Acute Lung Injury 01/2014 - 05/2006
5	Lung Injury 01/2014 - 03/2005
4	Carcinogenesis 01/2020 - 02/2015
4	Inflammation (Inflammations) 12/2013 - 06/2007
3	Cholangiocarcinoma 01/2020 - 01/2017
3	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020 - 01/2017
3	Neoplasms, Cystic, Mucinous, and Serous 11/2019 - 01/2017
3	Gallstones (Gallstone) 03/2019 - 09/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2012
3	Pancreatic Fistula (Pancreatic Fistulas) 12/2017 - 01/2017
3	Disease Progression 11/2016 - 01/2011
3	Ischemia 12/2012 - 06/2002
3	Chronic Pancreatitis 05/2012 - 08/2003
2	Cellulitis 01/2020 - 01/2016
2	Abscess 01/2020 - 01/2016
2	Hemorrhage 12/2017 - 01/2007
2	Appendicitis 01/2016 - 09/2011
2	Hypertrophy 01/2015 - 08/2009
2	Critical Illness (Critically Ill) 12/2012 - 08/2002
2	Autoimmune Pancreatitis 10/2012 - 05/2012
2	Malnutrition (Nutritional Deficiencies) 11/2011 - 08/2003
2	Fibrosis (Cirrhosis) 03/2011 - 09/2010
2	Reperfusion Injury 01/2009 - 07/2002
2	Wounds and Injuries (Trauma) 01/2008 - 09/2006

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 06/2020 - 08/2002
22	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
9	Gemcitabine FDA Link 11/2017 - 01/2009
7	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2002
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 09/2003
6	CytokinesIBA 06/2017 - 01/2005
5	Glycoproteins (Glycoprotein)IBA 06/2020 - 10/2013
5	Biological ProductsIBA 05/2019 - 08/2005
4	Mucin-4IBA 05/2017 - 10/2013
4	NF-kappa B (NF-kB)IBA 01/2017 - 08/2002
4	Insulin (Novolin)FDA Link 10/2013 - 08/2003
4	Interleukin-6 (Interleukin 6)IBA 10/2013 - 06/2007
4	Taurodeoxycholic AcidIBA 06/2007 - 10/2002
3	Cysteine (L-Cysteine)FDA Link 06/2020 - 01/2010
3	CollagenIBA 02/2019 - 03/2011
3	Blood Proteins (Serum Proteins)IBA 12/2018 - 10/2012
3	Fluorouracil (Carac)FDA LinkGeneric 02/2018 - 01/2012
3	Pharmaceutical PreparationsIBA 11/2017 - 04/2012
3	Thromboplastin (Tissue Factor)IBA 10/2015 - 12/2010
3	Therapeutic UsesIBA 01/2014 - 08/2009
3	lipoxin A4IBA 01/2014 - 02/2011
3	NucleosidesIBA 12/2013 - 01/2009
3	salicylhydroxamic acid (SHAM)IBA 03/2011 - 10/2002
3	LipopolysaccharidesIBA 04/2010 - 08/2009
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2017
2	ParaffinIBA 01/2020 - 01/2017
2	Chloride Channels (Chloride Channel)IBA 04/2019 - 11/2018
2	Fibronectins (Fibronectin)IBA 02/2019 - 11/2011
2	AntigensIBA 01/2018 - 01/2015
2	Histones (Histone)IBA 12/2017 - 01/2017
2	Nucleosomes (Nucleosome)IBA 06/2017 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2017 - 01/2016
2	Extracellular Matrix ProteinsIBA 06/2017 - 09/2010
2	Lysine (L-Lysine)FDA Link 01/2017 - 04/2007
2	Amylases FDA Link 01/2017 - 01/2008
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2015 - 05/2012
2	Equilibrative Nucleoside Transporter 1IBA 07/2014 - 08/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2014 - 02/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2014 - 01/2010
2	C-Reactive ProteinIBA 10/2013 - 01/2006
2	AlbuminsIBA 10/2013 - 05/2005
2	Factor VIIa (Activated Factor VII)IBA 12/2012 - 06/2007
2	ProteomeIBA 10/2012 - 11/2011
2	Tissue Inhibitor of Metalloproteinase-1IBA 03/2011 - 05/2006
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2011 - 07/2002
2	Interleukin-10 (Interleukin 10)IBA 06/2007 - 05/2006
2	Peptide Hydrolases (Proteases)FDA Link 06/2007 - 05/2006
2	Protease Inhibitors (Protease Inhibitor)IBA 06/2007 - 07/2002
2	Peroxidase (Myeloperoxidase)IBA 06/2007 - 05/2005
2	Peptides (Polypeptides)IBA 01/2007 - 09/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006 - 03/2005
2	Platelet Activating FactorIBA 05/2005 - 06/2002
2	lexipafantIBA 05/2005 - 06/2002

Therapy/Procedure

18	Therapeutics 01/2022 - 08/2009
13	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
7	Cholecystectomy 01/2020 - 01/2008
4	Aftercare (After-Treatment) 01/2020 - 07/2003
4	Pancreaticoduodenectomy 12/2019 - 01/2017
4	Palliative Care (Palliative Therapy) 10/2011 - 04/2002
3	Appendectomy 01/2020 - 01/2004
3	Immunotherapy 12/2019 - 11/2016
3	Adjuvant Chemotherapy 01/2015 - 12/2011
3	Intra-Arterial Infusions 01/2014 - 01/2012
3	Ligation 01/2014 - 03/2005
2	Hepatectomy 01/2018 - 08/2013
2	Pancreatectomy 12/2017 - 01/2015
2	Radiotherapy 08/2013 - 01/2005
2	Enteral Nutrition (Feeding, Tube) 09/2012 - 01/2009
2	Resuscitation 01/2009 - 06/2006
2	Critical Care (Surgical Intensive Care) 01/2009 - 07/2003